2007
DOI: 10.1128/aem.00791-07
|View full text |Cite
|
Sign up to set email alerts
|

Directed Evolution of AraC for Improved Compatibility of Arabinose- and Lactose-Inducible Promoters

Abstract: Synthetic biological systems often require multiple, independently inducible promoters in order to control the expression levels of several genes; however, cross talk between the promoters limits this ability. Here, we demonstrate the directed evolution of AraC to construct an arabinose-inducible (P BAD ) system that is more compatible with IPTG (isopropyl-␤-D-1-thiogalactopyranoside) induction of a lactose-inducible (P lac ) system. The constructed system is 10 times more sensitive to arabinose and tolerates … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
95
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 97 publications
(97 citation statements)
references
References 35 publications
2
95
0
Order By: Relevance
“…Plasmid pBAD33* is a modified version of pBAD33 (44) harboring a mutant form of araC with cysteine 280 converted to a premature stop codon (AraC-C280*). This mutation has been previously observed to reduce inhibition of gene expression from the P BAD promoter in the presence of IPTG (45), allowing the use of both inducing agents simultaneously. The plasmid was generated by PCR using primers 51 and 52 with template pBAD33, which introduced the C280* mutation and an XhoI restriction site at the 5= and 3= ends.…”
Section: Methodsmentioning
confidence: 99%
“…Plasmid pBAD33* is a modified version of pBAD33 (44) harboring a mutant form of araC with cysteine 280 converted to a premature stop codon (AraC-C280*). This mutation has been previously observed to reduce inhibition of gene expression from the P BAD promoter in the presence of IPTG (45), allowing the use of both inducing agents simultaneously. The plasmid was generated by PCR using primers 51 and 52 with template pBAD33, which introduced the C280* mutation and an XhoI restriction site at the 5= and 3= ends.…”
Section: Methodsmentioning
confidence: 99%
“…In addition, IPTG is known to be an inhibitor of the araBADp expression system. Crosstalk between araBADp and lac operator-controlled promoters prevents them from being used simultaneously in the same cell (53). Under the time-delayed in vivo assembly conditions, this inhibitory effect of IPTG was advantageous, since the repression of the araBAD promoter was further strengthened.…”
Section: Resultsmentioning
confidence: 97%
“…The construction of many pathway variations and permutations [ 50] can be more efficiently handled by better assembly techniques rather than through synthesis of each permutation. For example, techniques such as ligation-free assembly [ 51,52] and BioBricks [ 53] are enabling rapid construction of operons and pathways from existing DNA fragments or genes. The BioBrick method, in particular, has the interesting property that the end result of assembly has the same restriction sites as at the start of the assembly-that is, each stage of assembly uses the enzymes and processes identical to the previous stage.…”
Section: Production Hostmentioning
confidence: 99%